Cross-sectional associations of serum perfluoroalkyl acids and thyroid hormones in U.S. Adults: Variation according to TPOAb and iodine status (NHANES 2007-2008)

Environmental Health Perspectives

Volumn 124, Issue 7, 2016, Pages 935-942

  Webster, Glenys M ^a,b   Rauch, Stephen A ^c   Marie, Nathalie Ste ^a   Mattman, Andre ^d   Lanphear, Bruce P ^a,b   Venners, Scott A ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; COMMUNITY CARE; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROXINE BLOOD LEVEL; WORLD HEALTH ORGANIZATION; YOUNG ADULT; ANALYSIS; BLOOD; ENVIRONMENTAL EXPOSURE; NUTRITION; POLLUTANT; STATISTICS AND NUMERICAL DATA;

FLUOROCARBON; IODINE; POLLUTANT; THYROID HORMONE;

ADULT; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; IODINE; MALE; MIDDLE AGED; NUTRITION SURVEYS; THYROID HORMONES; YOUNG ADULT;

EID: 84977083415     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1409589     Document Type: Article

References (49)

1. Asvold BO, Bjøro T, Nilsen TIL, Vatten LJ. 2007. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med 167:1428-1432, doi:10.1001/archinte.167.13.1428.
2. Bloom MS, Kannan K, Spliethoff HM, Tao L, Aldous KM, Vena JE. 2010. Exploratory assess-ment of perfluorinated compounds and human thyroid function. Physiol Behav 99:240-245.
3. Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL. 2006. Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ Health Perspect 144:1865-1871, doi:10.1289/ehp.9466.
4. Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, et al. 2002. Toxicity of ammonium perfluoro-octanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 69:244-257.
5. Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY. 2011. Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005-2006 and 2007-2008. Thyroid 21:419-427, doi:10.1089/thy.2010.0077.
6. Chan E, Burstyn I, Cherry N, Bamforth F, Martin JW. 2011. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res 111:559-564.
7. Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, et al. 2007. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 234:21-33.
8. Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, et al. 2008. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 243:330-339.
9. Chevrier J, Gunier RB, Bradman A, Holland NT, Calafat AM, Eskenazi B, et al. 2013. Maternal urinary bisphenol A during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ Health Perspect 121:138-144, doi:10.1289/ehp.1205092.
10. Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, et al. 2010. Illustrating bias due to conditioning on a collider. Int J Epidemiol 39:417-420, doi:10.1093/ije/dyp334.
11. Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P. 2009. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 117:1380-1386, doi:10.1289/ehp.0900633.
12. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. 2006. Community exposure to perfluoro-octanoate: relationships between serum concentrations and exposure sources. J Occup Env Med 48:759-770.
13. Gilliland F. 1992. Fluorocarbons and Human Health: Studies in Occupational Cohort [PhD Dissertation]. Minneapolis, MN:University of Minnesota, Minneapolis.
14. Glinoer D. 1999. What happens to the normal thyroid during pregnancy? Thyroid 9:631-935.
15. Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G, et al. 2012. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect 120:668-673, doi:10.1289/ehp.1104034.
16. Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A. 2005. Renal clearance of perfluoro-octane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 99:253-261.
17. Health Canada. 2010. Report on Human Biomonitoring of Environmental Chemicals in Canada—Results of the Canadian Health Measures Survey Cycle 1 (2007-2009). Available: http://www.hc-sc.gc.ca/ewh-semt/pubs/contaminants/chms-ecms/index-eng.php [accessed 4 July 2015].
18. Jain RB. 2013. Association between thyroid profile and perfluoroalkyl acids: data from NHNAES 2007-2008. Environ Res 126:51-59, doi:10.1016/j.envres.2013.08.006.
19. Ji K, Kim S, Kho Y, Paek D, Sakong J, Ha J, et al. 2012. Serum concentrations of major perfluori-nated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones. Environ Int 45:78-85, doi:10.1016/j.envint.2012.03.007.
20. Johnson PI, Sutton P, Atchley DS, Koustas E, Lam J, Sen S, et al. 2014. The Navigation Guide— evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect 122:1028-1039, doi:10.1289/ehp.1307893.
21. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluoroalkyl chemi-cals in the U.S. population: 1999-2008. Environ Sci Technol 45:8037-8045, doi:10.1021/es1043613.
22. Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, et al. 2011. Trans-placental transfer of thirteen perfluori-nated compounds and relations with fetal thyroid hormones. Environ Sci Technol 45:7465-7472, doi:10.1021/es202408a.
23. Kissa E. 2001. Fluorinated Surfactants and Repellents. New York:Marcel Dekker Inc.
24. Knox SS, Jackson T, Frisbee SJ, Javins B, Ducatman AM. 2011. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci 36:403-410.
25. Kuklenyik Z, Needham LL, Calafat AM. 2005. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem 77:6085-6091, doi:10.1021/ac050671l.
26. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. 2003. Exposure to perfluorooc-tane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 74:382-392.
27. Lin CY, Wen LL, Lin LY, Wen TW, Lien GW, Hsu SHJ, et al. 2013. The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults. J Hazard Mater 244-245:637-644, doi:10.1016/j.jhazmat.2012.10.049.
28. Lopez-Espinosa MJ, Mondal D, Armstrong B, Bloom MS, Fletcher T. 2012. Thyroid function and perfluoroalkyl acids in children living near a chemical plant. Environ Health Perspect 120:1036-1041, doi:10.1289/ehp.1104370.
29. Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL. 2005. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215:149-169.
30. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. 2010. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect 118:686-692, doi:10.1289/ehp.0901584.
31. Multum Lexicon. 2015. Lexicon Plus. All You Need in One Easy-to-Read Database. Available: http://multum.com/lexicon.html [accessed 18 October 2015].
32. NHANES. 2007a. National Health and Nutrition Examination Survey. NHANES 2007-2008. Available: http://wwwn.cdc.gov/nchs/nhanes/search/nhanes07_08.aspx [accessed 4 July 2014].
33. NHANES. 2007b. National Health and Nutrition Examination Survey. 2007-2008 Lab Methods. Available: http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/lab_methods_07_08.htm [accessed 4 July 2014].
34. Olsen GW, Burris JM, Burlew MM, Mandel JH. 2003. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluoro-octanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45:260-270.
35. Olsen GW, Zobel LR. 2007. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluoro chemical production workers. Int Arch Occup Environ Health 81:231-246.
36. Pearce EN. 2012. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes 19:408-413, doi:10.1097/MED.0b013e328355cd6c.
37. Romano ME, Webster GM, Vuong AM, Thomas Zoeller R, Chen A, Hoofnagle AN, et al. 2015. Gestational urinary bisphenol A and maternal and newborn thyroid hormone concentrations: the HOME Study. Environ Res 138:453-460, doi:10.1016/j.envres.2015.03.003.
38. Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff JL. 2002. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 68:249-264.
39. Steenland K, Fletcher T, Savitz D. 2011. C8 Science Panel Status Report: PFOA and Adult Thyroid Disease in the Mid-Ohio Valley. Available: http://www.c8sciencepanel.org/pdfs/Status_Report_C8_and_thyroid_disease_5Dec2011.pdf [accessed 14 October 2012].
40. Tahboub R, Arafah BM. 2009. Sex steroids and the thyroid. Best Pract Res Clin Endocrinol Metab 23:769-780, doi:10.1016/j.beem.2009.06.005.
41. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 74:369-381.
42. Wang Y, Rogan WJ, Chen PC, Lien GW, Chen HY, Tseng YC, et al. 2014. Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan Maternal and Infant Cohort Study. Environ Health Perspect 122:529-534, doi:10.1289/ehp.1306925.
43. Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, et al. 2013. Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study. Environ Health 12:76, doi:10.1186/1476-069X-12-76.
44. Webster GM, Venners SA, Mattman A, Martin JW. 2014. Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study. Environ Res 133:338-347, doi:10.1016/j.envres.2014.06.012.
45. Wen LL, Lin LY, Su TC, Chen PC, Lin CY. 2013. Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007-2010. J Clin Endocrinol Metab 98:E1456-E1464, doi:10.1210/jc.2013-1282.
46. WHO (World Health Organization). 2004. Iodine Status Worldwide: Who Global Database on Iodine Deficiency. Available: http://www.who.int/vmnis/iodine/status/en/ [accessed 1 May 2014].
47. Winquist A, Steenland K. 2014. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology 25:255-264, doi:10.1097/EDE.0000000000000040.
48. Yu WG, Liu W, Jin YH. 2009a. Effects of perfluoro octane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem 28:990-996.
49. Yu WG, Liu W, Jin YH, Liu XH, Wang FQ, Liu L, et al. 2009b. Prenatal and postnatal impact of perfluoro-octane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system. Environ Sci Technol 43:8416-8422.